Jiangsu Aikon Biopharmaceutical, a commonly used chemical reagent in the laboratory, has high purity.

Jiangsu Aikon Biopharmaceutical R&D Co., Ltd. is located at Xinghuo Road, High-tech Development Zone, Nanjing City, Jiangsu Province. It is dedicated to providing high-quality R&D reagents and fast delivery services for the drug development field. Its product offerings mainly include: basic chemical reagents, organic synthetic building blocks, pharmaceutical intermediates, and specialty chemicals. The company can provide reagent packaging from mg to kg levels and custom synthesis services for high-end chemicals.

Ren Fucong, Secretary-General of the China Chemical Reagent Industry Association, stated that the development of China's chemical reagent industry mainly faces three major challenges: First, there are many production enterprises, but they are small in scale. Due to the small usage volume of chemical reagents, railway authorities are generally unwilling to provide transportation services unless an entire freight car is chartered; if road transport is used, the toll fees are too high. As a result, chemical reagents are highly regional, generally only supplying surrounding areas, leading to a situation where the chemical reagent industry has many enterprises but small scales. Except for Tibet, every province, municipality, and autonomous region in China has chemical reagent production enterprises, totaling nearly 1,000. Among these, small enterprises with just a few or a dozen employees make up the majority. They operate in a decentralized manner, each acting independently, with low management levels, subpar technical skills, outdated equipment, and poor economic efficiency. Chemical reagent procurement website
Second, there is insufficient investment in research and development, resulting in low technological content and a limited variety of products. The overall advancement of the chemical reagent industry requires investment in funds, technology, talent, and advanced equipment. However, relevant authorities have long lacked the necessary investment in the chemical reagent industry; meanwhile, due to economic efficiency and other reasons, enterprises have insufficient investment in new product development and technological upgrades, leading to low technological content and a limited variety of products, making it difficult to meet market demands. Chemical reagent purchasing platform
Third, product quality is low, performance is unstable, and there is severe disorderly competition in the market. Among the existing nearly 1,000 chemical reagent production enterprises, only about five to six hundred have production licenses, with nearly half operating without licenses. Counterfeit and substandard products flood the market. Although quality inspection, industry and commerce departments, and others have taken some necessary measures, daily supervision has not kept up, resulting in limited effectiveness. Laboratory chemical reagent purchase

Aikon has years of experience collaborating with domestic and international drug R&D-related enterprises and institutions, deeply understanding the needs of R&D professionals. To improve scientific research efficiency, it is now focusing on building a one-stop procurement platform ranging from basic reagents to high-end chemicals. The platform includes brands from Aikon’s partners as well as Aikon’s own brand (Aikon Research Selection). Users can place orders online independently, saying goodbye to cumbersome procurement processes.